Green Cross Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 5.08 M
- Company Age 24 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Green Cross Therapeutics
Green Cross Therapeutics Private Limited (GCTPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 February 2000 and has a history of 24 years and 11 months. Its registered office is in Kolkata, West Bengal, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 5.08 M, as per Ministry of Corporate Affairs (MCA) records.
Kishore Bhattacharya, Sekhar Krishnan, Sreoshi Moitra, and One other member serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U05150WB2000PTC091185
- Company No.
091185
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Who are the key members and board of directors at Green Cross Therapeutics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sekhar Krishnan  | Director | 01-Oct-2014 | Current |
| Kishore Bhattacharya | Director | 01-Aug-2007 | Current |
| Sreoshi Moitra | Director | 17-Jun-2021 | Current |
| Deborshi Roy | Director | 17-Jun-2021 | Current |
Financial Performance of Green Cross Therapeutics.
Green Cross Therapeutics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Green Cross Therapeutics?
In 2017, Green Cross Therapeutics had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tcg Software Services Private LimitedSekhar Krishnan and Deborshi Roy are mutual person
Tcg Chembiotek Infrastructure Private LimitedKishore Bhattacharya is a mutual person
- Juggernaut Homes Pvt Ltd
Sekhar Krishnan is a mutual person
Mcpi Private LimitedSekhar Krishnan is a mutual person
Tcg Refineries Private LimitedKishore Bhattacharya is a mutual person
- Institute Of Molecular Medicine
Kishore Bhattacharya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Cross Therapeutics?
Unlock and access historical data on people associated with Green Cross Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Cross Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Cross Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
